An Oct. 7 meeting was part of the FDA's review process of pending applications for IQOS ILUMA. "We encourage the FDA to continue efforts to establish a timely scientific review process for smoke-free ...
Hosted on MSN
Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product
Philip Morris International (NYSE:PM) is urging the U.S. Food and Drug Administration to allow the company to continue marketing its heated tobacco products in the U.S. as a “modified risk tobacco ...
(Reuters) - The U.S. Food and Drug Administration on Tuesday said it would allow Philip Morris to sell a heated tobacco product called IQOS in the United States, a major victory for the international ...
Philip Morris International is urging federal regulators to let it continue marketing its IQOS heated tobacco products in the U.S. as posing fewer health risks than traditional cigarettes. The tobacco ...
Fisher Asset Management holds $2.82 million worth of Philip Morris International Inc. (NYSE:PM) shares, helping it secure a place on our list of billionaire Ken Fisher’s 10 consumer stock picks with ...
The applications mark the next step in the company’s mission to offer adults who smoke a portfolio of innovative, scientifically substantiated nicotine alternatives that can help make America free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results